expert roundtables by Brian D. Moseley, MD; John M. Stern, MD; and James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES
Treatment options for patients with drug-resistant focal epilepsy who are not eligible for surgical resection include devices such as deep brain st......READ MORE
Few satisfactory explanations for sudden unexpected death in epilepsy (SUDEP) have been reported; thus, interest is growing in seeking biomarkers t......READ MORE
patient care perspectives by James W. Wheless, BScPharm, MD, FAAP, FACP, FAAN, FAES
Newer, efficacious antiepileptic drugs (AEDs) with improved side-effect profiles are becoming available for the treatment of pediatric patients wit......READ MORE
expert roundtables by Selim R. Benbadis, MD; Brian D. Moseley, MD; and James W. Wheless, BSPharm, MD, FAAP, FACP, FAAN, FAES
Distinguishing between focal onset (partial onset) seizures and primary generalized seizures is, at times, challenging in clinical practice. Our fe......READ MORE
expert roundtables by Selim R. Benbadis, MD; Brian D. Moseley, MD; and James W. Wheless, BSPharm, MD, FAAP, FACP, FAAN, FAES
More than 30% of patients with epilepsy will continue to have seizures despite initiating antiepileptic drug (AED) therapy. Adjunctive therapy can ......READ MORE
The selection of a specific antiepileptic drug (AED) is individualized, considering drug effectiveness for seizure type, age, comorbidities, and pa......READ MORE
